Diabetes: how to manage overweight and obesity in type 2 diabetes mellitus

Megan Wesling, Jennifer J D’Souza

Article Type

Review

Published

With the prevalence of type 2 diabetes increasing, this article discusses how it is essential that healthcare professionals assess how their patients’ current diabetes treatment is being managed to avoid further weight gain in those who are already overweight or obese.

Read more

A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond

Lalita Prasad-Reddy, Diana Isaacs

Article Type

Review

Published

Many of the agents used to treat type 2 diabetes have undesirable adverse effects of hypoglycemia and weight gain. Glucagon-like peptide-1 (GLP-1) receptor agonists represent a unique approach to the treatment of diabetes. In this article the authors discuss the various GLP-1 receptor agonists available on the market, specifically focusing on their relative efficacy, safety, and clinical differences as well as their potential benefits in addition to glucose lowering in type 2 diabetes, and describe the adverse effects and toxicities seen with these agents.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.